Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in ELVN held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 8.0M | $312.0M | 0.0% | 13.069% | 6.57% |
| 2 | FMR LLC | 6.8M | $267.7M | -3.9% | 11.213% | 0.01% |
| 3 | Polar Capital Holdings Plc | 5.1M | $198.6M | +44.2% | 8.318% | 0.71% |
| 4 | BlackRock, Inc. | 3.7M | $144.4M | +2.0% | 6.050% | 0.00% |
| 5 | COMMODORE CAPITAL LP | 3.3M | $128.4M | -30.2% | 5.377% | 7.43% |
| 6 | Vestal Point Capital, LP | 3.3M | $127.4M | -15.1% | 5.336% | 3.56% |
| 7 | Bellevue Group AG | 2.3M | $91.0M | β | 3.811% | 2.17% |
| 8 | CITADEL ADVISORS LLC | 1.9M | $73.4M | +29.8% | 3.073% | 0.03% |
| 9 | Fairmount Funds Management LLC | 1.9M | $72.7M | -50.0% | 3.047% | 5.25% |
| 10 | VR Adviser, LLC | 1.7M | $67.7M | -46.5% | 2.834% | 2.53% |
| 11 | Novo Holdings A/S | 1.3M | $50.2M | -13.5% | 2.102% | 4.07% |
| 12 | STATE STREET CORP | 1.1M | $42.8M | +3.6% | 1.792% | 0.00% |
| 13 | GEODE CAPITAL MANAGEMENT, LLC | 1.1M | $41.8M | +1.7% | 1.751% | 0.00% |
| 14 | Logos Global Management LP | 1.0M | $40.8M | +205.9% | 1.708% | 2.04% |
| 15 | Caption Management, LLC | 957K | $37.5M | β | 1.571% | 0.36% |
| 16 | Pictet Asset Management Holding SA | 930K | $36.4M | -28.7% | 1.526% | 0.04% |
| 17 | BAKER BROS. ADVISORS LP | 905K | $35.5M | +233.5% | 1.486% | 0.20% |
| 18 | Rock Springs Capital Management LP | 827K | $32.4M | +3.5% | 1.357% | 1.91% |
| 19 | Siren, L.L.C. | 746K | $29.3M | β | 1.225% | 0.81% |
| 20 | DIMENSIONAL FUND ADVISORS LP | 682K | $26.7M | +70.9% | 1.119% | 0.01% |
| 21 | First Turn Management, LLC | 624K | $24.5M | β | 1.024% | 2.73% |
| 22 | Candriam Luxembourg S.C.A. | 594K | $23.3M | +31.1% | 0.975% | 0.12% |
| 23 | Jones Hill Capital LP | 593K | $23.2M | β | 0.974% | 4.98% |
| 24 | Affinity Asset Advisors, LLC | 587K | $23.0M | β | 0.964% | 1.34% |
| 25 | MORGAN STANLEY | 519K | $20.3M | +25.9% | 0.851% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in ELVN β a direct measure of their conviction.
Filings activity in ELVN during Q1 2026, grouped by how each filer changed its position.
Institutions that opened a new ELVN position in Q1 2026
Institutions that fully closed their ELVN position in Q1 2026
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 160 | +26% | 83.86% | +49.77 pp | $2.36B | +146% |
| Q4 2025 | 127 | 5.2% | 34.09% | 8.06 pp | $958M | 19% |
| Q3 2025 | 134 | +5.5% | 42.15% | +0.51 pp | $1.18B | +1.2% |
| Q2 2025 | 127 | +2.4% | 41.64% | +7.63 pp | $1.17B | +22% |
| Q1 2025 | 124 | +9.7% | 34.01% | 3.92 pp | $955M | 10% |
| Q4 2024 | 113 | +11% | 37.93% | 3.44 pp | $1.07B | 8.3% |
| Q3 2024 | 102 | +8.5% | 41.37% | +3.14 pp | $1.16B | +8.2% |
| Q2 2024 | 94 | β | 38.23% | β | $1.07B | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying ELVN stock.
Based on Q1 2026 13F filings, institutional ownership of Enliven Therapeutics, Inc. stands at 83.9%, held across 160 reporting institutions.
ORBIMED ADVISORS LLC is the largest reported institutional holder of ELVN, with approximately 7,959,538 shares worth $0.31B as of Q1 2026.
Yes β 1 widely-followed marquee investor appear among the top 25 institutional holders of ELVN, including CITADEL ADVISORS LLC.
Our composite Smart Money Score for ELVN is 69 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
55 institutions opened new positions in ELVN during Q1 2026, while 22 fully exited. 98 added to existing positions and 5 trimmed.
ELVN institutional ownership rose by 49.77 percentage points quarter-over-quarter, with a net change of +33 holders.
The top 10 institutions account for 63.0% of all reported 13F value in ELVN, and the top 25 account for 83.6%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Enliven Therapeutics, Inc. (ELVN) Institutional Ownership